These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27349003)

  • 1. Morphological Changes of Trichomonas vaginalis Treated by Ornidazole: An In-Vitro Study.
    Cakan H; Polat E; Arda O; Cepni I; Dirican A; Sirekbasan S
    Clin Lab; 2016; 62(5):793-800. PubMed ID: 27349003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitrichomonal properties of derivatives of ethers containing amine and halogenarylalkyl groups].
    Białasiewicz D; Kotełko B; Kurnatowska A; Kwaśniewska J
    Wiad Parazytol; 1990; 36(5-6):281-5. PubMed ID: 2131703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the antitrichomonal activity of 5-nitroimidazole derivatives by hydrogen peroxide.
    Mattana A; Juliano C; Picci V; Franconi F; Cappuccinelli P
    New Microbiol; 1993 Oct; 16(4):359-65. PubMed ID: 8264426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen medium, antitrichomonal drug activity in vaginal liquids.
    Simonetti G; Simonetti N; D'Auria FD
    Drugs Exp Clin Res; 1989; 15(11-12):545-7. PubMed ID: 2637795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
    Wu J; Zhang M; Ding D; Tan T; Yan B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tinidazole on T. vaginalis in vitro].
    Savoia D; Martinetto P; Pugliese A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of sodium nitrite on Trichomonas vaginalis].
    Ryu JS; Park JW; Min DY
    Korean J Parasitol; 1995 Dec; 33(4):349-56. PubMed ID: 8591013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection.
    Sköld M; Gnarpe H; Hillström L
    Br J Vener Dis; 1977 Feb; 53(1):44-8. PubMed ID: 321095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro anti-Trichomonas vaginalis effects of a mixture of dihydroartemisinin and metronidazole].
    Tang ZH; Liu KY; Mei J; Gao XZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Dec; 28(6):416-21. PubMed ID: 21500527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.
    Mallo N; Lamas J; Leiro JM
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2476-84. PubMed ID: 23478970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of Trichomonas vaginalis sensitivity to nitroimidazole group preparations using solid nutrient media].
    Bednova VN; Vasil'ev MM
    Vestn Dermatol Venerol; 1982 Nov; (11):19-21. PubMed ID: 6984259
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphogenesis during division and griseofulvin-induced changes of the microtubular cytoskeleton in the parasitic protist, Trichomonas vaginalis.
    Noël C; Gerbod D; Delgado-Viscogliosi P; Fast NM; Younes AB; Chose O; Roseto A; Capron M; Viscogliosi E
    Parasitol Res; 2003 Apr; 89(6):487-94. PubMed ID: 12658461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of a new nitroimidazole derivative (CP 12 574) on 67 strains of T. vaginalis.
    Miltgen F; Dellenbach P; Kremer M
    Wiad Parazytol; 1973; 19(3):499-501. PubMed ID: 4542510
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of compounds with potential antiparasitic action. VIII. New oxime ethers in the 1-thiochromone system].
    Kadłubowski R; Błaszkowska J; Horwatt E
    Wiad Parazytol; 1990; 36(5-6):269-74. PubMed ID: 2131701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the molecular events linking to cell death induced by tetracycline in the amitochondriate protozoan Trichomonas vaginalis.
    Huang KY; Ku FM; Cheng WH; Lee CC; Huang PJ; Chu LJ; Cheng CC; Fang YK; Wu HH; Tang P
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6891-903. PubMed ID: 26303799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.